Briana C Patterson
Affiliation: Emory University
- Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor programBriana C Patterson
Emory University School of Medicine, Department of Pediatrics, M S, Emory Children s Center, 2015 Uppergate Drive, Suite 232 NE, Atlanta, Georgia 30322, USA
J Clin Endocrinol Metab 97:810-8. 2012..Many pediatric cancer survivors have endocrine conditions. Surveillance for late effects is recommended by national guidelines. Endocrine surveillance is recommended after alkylating agents, steroids, methotrexate, and radiation...
- Adrenal function testing in pediatric cancer survivorsBriana C Patterson
Division of Endocrinology, Department of Pediatrics, Emory University, Atlanta, Georgia, USA
Pediatr Blood Cancer 53:1302-7. 2009..Central adrenal insufficiency is observed after cranial radiation therapy for cancer. Screening at risk patients is recommended, but the best screening strategy is unknown...
- Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic TherapySwati V Elchuri
Division of Endocrinology and Metabolism, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia Electronic address
J Pediatr Adolesc Gynecol 29:393-9. 2016..To obtain anti-Müllerian hormone (AMH) levels in female childhood cancer survivors and determine the association of therapeutic exposures with diminished ovarian reserve (DOR)...
- Perceptions of body mass index (BMI) in pediatric cancer survivors and their providersSwati V Elchuri
Division of Endocrinology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia
Pediatr Blood Cancer 61:1445-50. 2014..Perceptions of BMI status in cancer survivors have been understudied. This study determines the accuracy of parent/survivor and provider reporting of BMI status in a cancer survivor program...
- Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics CommitteeSripriya Raman
Division of Pediatric Endocrinology S R, Children s Mercy Hospital, University of Missouri, Kansas City, Missouri 64111 University of Kansas Medical Center S R, Kansas City, Kansas 66160 Department of Pediatrics A G, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104 Division of Endocrinology and Diabetes A G, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 Department of Endocrine Neoplasia and Hormonal Disorders S G W, University of Texas MD Anderson Cancer Center, Houston, Texas 77030 Division of Endocrinology B S M, Department of Pediatrics, University of Minnesota Masonic Children s Hospital, Minneapolis, Minnesota 55455 Memorial Sloan Kettering Cancer Center C A S, New York, New York 10065 and Emory University Aflac Cancer and Blood Disorders Center of Children s Healthcare of Atlanta L R M, B C P, Atlanta, Georgia 30322
J Clin Endocrinol Metab 100:2192-203. 2015..This report summarizes the available evidence on whether GH therapy in childhood is associated with an increased risk of neoplasia during treatment or after treatment is completed...